Concepedia

P. Hohl

PH

11

Publications

561

Citations

11

H-Index

1988

Active since

Affiliations

Roche (Switzerland)(Current)

Basilea Pharmaceutica (Switzerland)

P. Hohl is an author at Roche (Switzerland) specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top concepts

Publications per year

1988–2004

11

Publications

11

In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant Staphylococci

Paul Hebeisen, Ingrid Heinze‐Krauss, Peter Angehrn et al. · Antimicrobial Agents and Chemotherapy · 2001 · 214 citations · Full text

BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant <i>Staphylococcus aureus</i> in Treatment of Experimental Endocarditis

José M. Entenza, P. Hohl, Ingrid Heinze‐Krauss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 91 citations · Full text

The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections

Román Pallarés, Olga Capdevila, Josefina Liñares et al. · The American Journal of Medicine · 2002 · 64 citations

, , +7

Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: Results of a Swiss multicenter study. Part I: Clinical results

E. Martin, T. Guggi, P. Hohl et al. · Infection · 1990 · 46 citations

, , +9

Fleroxacin: in-vitro activity worldwide against 20,807 clinical isolates and comparison to ciprofloxacin and norfloxacin

R. Paganoni, Christian Herzog, A.R. Braunsteiner et al. · Journal of Antimicrobial Chemotherapy · 1988 · 36 citations

Rows per page

1–5 of 11